[PHP39] Drug Pricing Reform in China – An Analysis of Piloted Pricing Approaches in the Context of International Experience
2015 Value in Health
Chen, Y. | Dong, P. | Yan, J. | Kornfeld, A. | Jaros, P. | Ma, F. | Toumi, M. |
Since 2009, the Chinese government has launched a global healthcare reform program aiming to control healthcare expenditure and increase the quality of care. As a part of this program, a new drug pricing reform was initiated starting 1stJune 2015. The objective of this study is to describe the changing landscape of drug pricing policy in China.